Current Issue

Cancer Treatment Reviews

September 2022Volume 109

Current Issue Links

• Articles in Press
• Past Issues

Submit Mobile

• Submit article

Explore

• Subscribe
• Reprints
   
• Career Opportunities
   

Publish

• Submit Article
   
• Aims and Scope
• For Authors
• Supports Open Access
   

Connect

• Alerts
• Twitter
   

Articles in Press

• 
  Review article

  Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: which role for gene expression assays?

  Garufi et al.

  Published online: August 11, 2022
• 
  Controversy

  Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias

  Kfoury et al.

  Published online: August 10, 2022
• 
  Review article

  Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: a systematic literature review

  Graham et al.

  Published online: August 10, 2022
• 
  Review article

  Refining patient selection of MET-activated non-small cell lung cancer through biomarker precision

  GY Lai et al.

  Published online: August 1, 2022

View All

Issue Highlights

• Review articleOpen Access

  GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee

  Woopen et al.

  Published online: April 30, 2022
• 

  Hot Topic

  Systematic review of the CUP trials characteristics and perspectives for next-generation studies

  Rassy et al.

  Published online: May 6, 2022
• 

  Anti-tumour TreatmentOpen Access

  The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines

  Wei et al.

  Published online: May 4, 2022
• 

  Review articleOpen Access

  The gut wall’s potential as a partner for precision oncology in immune checkpoint treatment

  Hone Lopez et al.

  Published online: May 7, 2022

About

Cancer Treatment Reviews

(Incorporating Evidence-based Oncology) is an international review journal that will keep both the clinician and researcher abreast of modern concepts and developments in cancer treatment research through the publication of state of the art, authoritative reviews; evidence-based reviews (using a priori defined selection process to identify key articles from the literature and reviewing them in the form of a structured abstract, evidence summary and commentary); and systematic reviews.

More

Metrics

Metrics

##

Impact Factor

##

5-Year Impact Factor

• More Journal Metrics
   
• Submit a Manuscript
   
• Top Social Media Articles
   
• Time to Online Publication
   

COVID-19

• 

  Complications of TreatmentOpen Access

  SARS-CoV-2 and cancer: Are they really partners in crime?

  van Dam et al.

  Published online: July 10, 2020
• Anti-tumour Treatment

  Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics

  Fares et al.

  Published online: June 29, 2020
• Hot Topic

  Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities

  Fontana et al.

  Published online: June 10, 2020
• Hot Topic

  Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)

  Slimano et al.

  Published online: June 22, 2020
• 

  Hot Topic

  Cancer and COVID-19: Unmasking their ties

  Addeo et al.

  Published online: June 3, 2020
• 

  Systematic or Meta-analysis Studies

  The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer

  Surujballi et al.

  Published online: March 23, 2021

Most Read (Last 30 Days)

• 
  New Drugs

  Open Access

  A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC)

  Abuhelwa et al.

  Published online: April 13, 2022
• 
  Anti-tumour Treatment

  Open Access

  The current clinical landscape of personalized cancer vaccines

  Fritah et al.

  Published online: March 24, 2022
• 
  Anti-tumour Treatment

  Open Access

  Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

  Garcia et al.

  Published online: March 26, 2020
• 
  Anti-tumour Treatment

  Open Access

  Immunotherapy in non-small cell lung cancer harbouring driver mutations

  Addeo et al.

  Published online: March 18, 2021
• 
  Complications of Treatment

  Open Access

  Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management

  Swain et al.

  Published online: March 11, 2022
• 
  Review article

  Open Access

  Roadmap to cure multiple myeloma

  Rodriguez-Otero et al.

  Published online: August 31, 2021

Most Cited (Previous 3 Years)

Tweets by OncologyAdvance